Why IMU is a multi multi bagger, page-8158

As Leslie has made reference to several times we are "waiting for the ink to dry" on the pre clincal  investigations for OnCARlytics  resulting from the strategic collaborative partnerships with both Cellarity and Eureka Theraputics to evaluate their products CYCART-19 and ARTEMIS in combination with CD19.

This will be big news and will position Imugene to be a major player in Immunotherapy.

On May 24th 2021 the ground breaking market news of Imugene's new cancer therapy CD19 OnCARlytics was released.

In this presentation Professor Yuman Fong declared

"What we have done here in this project is that we have actually figured out a way of putting CD19 on any bad cancer and that involves using a virus that we have actually bred to be specific only for cancer and to leave normal cells alone.
Using this virus called CF33 we've been able also to insert the gene for human CD19 and therefore this virus now can theoretically circulate the body, find cancer cells, infect them specifically and not infect those cells that are normal.
And then not only will it start killing the cancer cells but also put in its local area this marker guide called CD19 so that we can then give immune cells trained to kill cells expressing this type of protein to be a secondary killing agent for cancer."

And in celebration of this I propose a new anthem will be sung by team Imugene ,,,